Nerviano Medical Sciences
Clinical trials sponsored by Nerviano Medical Sciences, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New hope for tough lung cancer? early trial tests novel drug combo Results expected Oct 2026 (estimated)
- New hope for recurrent ovarian cancer? early trial combines novel PARP inhibitor with chemo Results expected May 2027 (estimated)